Artia Global Partners LP Quant / Systematic

Location: Miami, FL

CIK: 0001937964 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $290M (100.0% shares, 0.0% debt)

Holdings (34)

NVO NOVO-NORDISK A S 19.0%
Value $55.17M Shares 340,906 Est. Cost $136.88 Unrealized
MRK MERCK & CO INC 13.1%
Value $37.99M Shares 329,200 Est. Cost $93.96 Unrealized +11.2%
ARGX ARGENX SE 6.2%
Value $18.1M Shares 46,438 Est. Cost $381.19 Unrealized
BIIB BIOGEN INC 5.1%
Value $14.89M Shares 52,275 Est. Cost $278.85 Unrealized +6.8%
AZN ASTRAZENECA PLC 4.7%
Value $13.65M Shares 190,752 Est. Cost $69.76 Unrealized
ABBV ABBVIE INC 4.2%
Value $12.24M Shares 90,821 Est. Cost $137.22 Unrealized -2.6%
MRNA MODERNA INC 3.5%
Value $10.29M Shares 84,719 Est. Cost $163.68 Unrealized -18.5%
IMMUNOGEN INC 3.5%
Value $10.25M Shares 543,358 Est. Cost $18.87 Unrealized
SEAGEN INC 3.4%
Value $9.849M Shares 51,175 Est. Cost $128.51 Unrealized
IVERIC BIO INC 3.3%
Value $9.633M Shares 244,861 Est. Cost $21.41 Unrealized
APLS APELLIS PHARMACEUTICALS INC 3.2%
Value $9.378M Shares 102,940 Est. Cost $86.28 Unrealized 0.0%
SRPT SAREPTA THERAPEUTICS INC 3.0%
Value $8.837M Shares 77,162 Est. Cost $128.81 Unrealized 0.0%
89BIO INC 3.0%
Value $8.821M Shares 465,465 Est. Cost $18.95 Unrealized
ROIV ROIVANT SCIENCES LTD 2.9%
Value $8.31M Shares 824,363 Est. Cost $8.81 Unrealized +1.5%
LLY LILLY ELI & CO 2.6%
Value $7.594M Shares 16,193 Est. Cost $345.79 Unrealized +19.0%
BMRN BIOMARIN PHARMACEUTICAL INC 2.3%
Value $6.801M Shares 78,465 Est. Cost $101.34 Unrealized -7.1%
VRTX VERTEX PHARMACEUTICALS INC 2.2%
Value $6.445M Shares 18,314 Est. Cost $324.44 Unrealized +3.9%
AXSM AXSOME THERAPEUTICS INC 2.2%
Value $6.313M Shares 87,848 Est. Cost $73.77 Unrealized 0.0%
VKTX VIKING THERAPEUTICS INC 2.1%
Value $6.218M Shares 383,580 Est. Cost $18.01 Unrealized +16.3%
NBIX NEUROCRINE BIOSCIENCES INC 1.5%
Value $4.244M Shares 45,000 Est. Cost $117.13 Unrealized -16.6%
BNTX BIONTECH SE 1.4%
Value $4.005M Shares 37,108 Est. Cost $150.22 Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 1.1%
Value $3.103M Shares 112,340 Est. Cost $25.03 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 1.0%
Value $3.034M Shares 15,971 Est. Cost $213.29 Unrealized -7.1%
TMO THERMO FISHER SCIENTIFIC INC 0.9%
Value $2.655M Shares 5,088 Est. Cost $524.96 Unrealized +2.0%
INTRA-CELLULAR THERAPIES INC 0.9%
Value $2.634M Shares 41,600 Est. Cost $52.92 Unrealized
PCVX VAXCYTE INC 0.7%
Value $1.925M Shares 38,555 Est. Cost $44.46 Unrealized +6.6%
CYMABAY THERAPEUTICS INC 0.6%
Value $1.854M Shares 169,277 Est. Cost $8.72 Unrealized
PLRX PLIANT THERAPEUTICS INC 0.6%
Value $1.812M Shares 100,000 Est. Cost $23.67 Unrealized 0.0%
CRL CHARLES RIV LABS INTL INC 0.5%
Value $1.452M Shares 6,905 Est. Cost $226.63 Unrealized -12.2%
TYRA TYRA BIOSCIENCES INC 0.3%
Value $771K Shares 45,253 Est. Cost $11.89 Unrealized +22.0%
WAT WATERS CORP 0.3%
Value $758K Shares 2,845 Est. Cost $316.35 Unrealized -12.0%
BMEA BIOMEA FUSION INC 0.2%
Value $559K Shares 25,452 Est. Cost $31.30 Unrealized 0.0%
MORPHOSYS AG 0.1%
Value $325K Shares 43,499 Est. Cost $7.47 Unrealized
GRITSTONE BIO INC 0.1%
Value $186K Shares 95,170 Est. Cost $1.95 Unrealized